IL33 and cancer: In sum, the biological consequence of IL-33/ST2 signaling on tumorigenesis and cancer treatment is complex and dictated by the site of expression, local concentration, and distribution of different IL-33 isoforms and their receptors (ST2L and sST) together with the main types of responsive cells in the TME.